ACM
ARNA

Adalta Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Adalta Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,010
Closed -$231K – 101
2020
Q4 		$231K Sell
3,010
-480
-14% -$36K 0.15% 63
2020
Q3 		$261K Buy
+3,490
New +$233K 0.19% 52

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Adalta Capital Management's ARNA Position: Q1 2021 in Review

Adalta Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2021, closing a stake of 3,010 shares — an estimated $231K sold.

Adalta Capital Management first reported a position in ARNA in Q3 2020 and held it in 2 quarters. The position peaked at $261K in Q3 2020. 235 funds tracked by Wall St. Rank hold ARNA as of Q1 2021.

  • Adalta Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2021 after selling out during the quarter.
  • Adalta Capital Management sold 3,010 Arena Pharmaceuticals Inc shares in Q1 2021, an estimated $231K.
  • Adalta Capital Management first reported a position in Arena Pharmaceuticals Inc in Q3 2020 and held it in 2 quarters.
  • Adalta Capital Management's Arena Pharmaceuticals Inc position peaked at $261K in Q3 2020.
  • 235 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2021.

Based on Adalta Capital Management's 13F filing for Q1 2021, filed 18 May 2021.